Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel SureClick Auto-injector Failure Rate in RA
NCT00346294Phase 4Completed
- Sponsor
- Amgen
- Start
- Jan 2006
- Primary completion
- Mar 2006
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Jan 2006; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00346294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346294.